The company operates a portfolio of coal, gas, and renewable power plants in India and Bangladesh, selling electricity primarily to state-owned distribution companies under long-term contracts.
The company lacks a durable moat as evidenced by negative average ROE and net margins. While long-term power purchase agreements provide revenue visibility, the business is a price-taker in a regulated utility market with high capital intensity and significant fuel supply risks.
Historical capital allocation has been poor, characterized by massive debt accumulation, non-operational assets like the Samalkot gas plant, and the loss of control over the Butibori project to lenders. Recent efforts focus on deleveraging and pivoting to solar/BESS to repair the balance sheet.
The company's attempt to pivot toward renewable energy and battery storage was strangled by its own history. The weight of legacy debt and the inability to generate cash from non-operational gas assets led to a liquidity trap, while ongoing criminal investigations and regulatory sanctions against leadership paralyzed strategic execution. As legal penalties mounted and lenders seized remaining productive assets, the equity was diluted to near-zero to satisfy creditors, proving that a business with broken integrity and negative returns cannot borrow its way to a new identity.
RichFakir rates Reliance Power Ltd's business quality as poor — 12/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Reliance Power Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Reliance Power Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Reliance Power Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →